Acro Biomedical (ACBM) EBIT Growth (3y) (2019 - 2026)
Analysis
Acro Biomedical (ACBM) EBIT Growth (3y) (2019 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Colgate Palmolive | 70.27 Bn | 68.90 Bn | 3.30 Bn | 1.42% |
| 2 | Kenvue | 34.17 Bn | 33.06 Bn | 2.30 Bn | -0.14% |
| 3 | Kimberly Clark | 32.86 Bn | 31.91 Bn | 1.60 Bn | 77.60% |
| 4 | Bath & Body Works | 3.85 Bn | 3.05 Bn | 692.00 Mn | 4.74% |
| 5 | Prestige Consumer Healthcare | 2.32 Bn | 2.26 Bn | - | - |
| 6 | Perrigo | 1.99 Bn | 1.59 Bn | 313.90 Mn | -25.49% |
| 7 | Herbalife | 1.32 Bn | 946.20 Mn | 1.03 Bn | 1.31% |
| 8 | Edgewell Personal Care | 1.24 Bn | 842.99 Mn | 242.50 Mn | -33.81% |
| 9 | TFA Therapeutics | 1.02 Bn | 1.02 Bn | - | - |
| 10 | Acro Biomedical | 1.80 Mn | 1.80 Mn | - | 82.35% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 82.35% |
| Dec 31, 2025 | 83.91% |
| Sep 30, 2025 | 69.38% |
| Jun 30, 2025 | 84.95% |
| Mar 31, 2025 | 86.85% |
| Dec 31, 2024 | 86.51% |
| Sep 30, 2024 | 85.51% |
| Jun 30, 2024 | 77.46% |
| Mar 31, 2024 | 43.47% |
| Sep 30, 2023 | -181.08% |
| Jun 30, 2023 | -270.59% |
| Mar 31, 2023 | -271.06% |
| Dec 31, 2022 | -273.61% |
| Sep 30, 2022 | -126.03% |
| Jun 30, 2022 | -141.75% |
| Mar 31, 2022 | -163.49% |
| Dec 31, 2021 | -244.49% |
| Sep 30, 2021 | -173.98% |
| Jun 30, 2021 | -86.64% |
| Mar 31, 2021 | -37.18% |